Gujarat Kidney & Super Speciality Ltd
NSE: GKSL BSE: 544666Healthcare
Incorporated in 2019, Gujarat Kidney and Super Speciality Limited specializes in providing multispeciality healthcare services.[1]
₹143
52W: ₹98.2 — ₹148
PE 123 · Book ₹4.01 · +3466% vs bookMarket Cap₹1,131 Cr
Stock P/E123Price to Earnings
ROCE57.7%Return on Capital
ROE50.2%Return on Equity
Div. Yield0%Face Value ₹2
Strengths
- +Company has a good return on equity (ROE) track record: 3 Years ROE 41.6%
- +Debtor days have improved from 226 to 133 days.
Weaknesses
- −Stock is trading at 35.0 times its book value
- −Though the company is reporting repeated profits, it is not paying out dividend
- −Company might be capitalizing the interest cost
Shareholding Pattern
Promoters71.45%
FIIs4.89%
DIIs0.56%
Public23.1%
| Category | Dec 2025 | Mar 2026 |
|---|---|---|
| Promoters | 71.45% | 71.45% |
| FIIs | 10.47% | 4.89%▼5.6 |
| DIIs | 1.67% | 0.56%▼1.1 |
| Public | 16.4% | 23.1%▲6.7 |
Financial Statements
| Metric | Sep 2024 | Dec 2024 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Sales | 9.41 | 8.51 | 11.45 | 9.64 | 9.76 |
| Expenses | 4.55 | 4.7 | 5.12 | 5.55 | 5.62 |
| Operating Profit | 4.86 | 3.81 | 6.33 | 4.09 | 4.14 |
| OPM % | 51.65% | 44.77% | 55.28% | 42.43% | 42.42% |
| Net Profit | 2.96 | 2.21 | 3.9 | 2.3 | 2.33 |
| EPS ₹ | 18.39 | 13.73 | 0.69 | 0.4 | 0.3 |
AI Insights
Revenue Trend
Mar 2025 revenue at ₹35.17Cr, up 637.3% YoY. OPM at 43.9%.
Debt Position
Borrowings at ₹16.91Cr. Debt-to-equity ratio: 0.83x. Moderate leverage.
Margin & Efficiency
ROCE improving from 0% (Mar 2023) to 57.72% (Mar 2025). Working capital days: -26.88.
Valuation
PE 123x with 57.7% ROCE. Price is 3466% above book value of ₹4.01. Dividend yield: 0%.
Recent Announcements
- Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 2d
- Announcement under Regulation 30 (LODR)-Monitoring Agency Report 2d - Brickwork Ratings reports FY26 Q4 IPO proceeds utilization of Rs 250.80 crore, with no deviation.
- GKSL Scales Up Renal Care: 100 Units AI-Powered Haemodialysis Machines To Be Inducted Across Network. First 8 Machines To Go Live At Gujarat Multi Speciality Hospital Godhra Gujarat Within 10 Days Following Completion Of All Required Inspections 14 May - GKSL to procure 100 AI haemodialysis machines; 8 to go live at Godhra within 10 days.
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 30 Apr - Company filed initial large corporate disclosure; outstanding borrowing was Rs 1.23 crore and not a large corporate.
- Announcement under Regulation 30 (LODR)-Acquisition 27 Apr - Board approved new Company Secretary and WOS incorporation for healthcare expansion in Bharuch, effective 27 April 2026.